Please assess the completion status of the following clinical trial:

Trial Title: A Study to Characterize the Abuse Liability of ALO-02 in Healthy, Non-Dependent, Recreational Opioid Abusers

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1
- Number of Arms: 6.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy subjects.~* Non-dependent, recreational opioid users. (Must use opioid for non-therapeutic purposes on at least 10 occassions within the last year before Screening Visit, and at least once in 8 weeks before the Screening Visit.~Exclusion Criteria:~* Diagnosis of substance and/or alcohol dependence.~* Subject has participated in, is currently participating in, or is seeking treatment for substance and/or alcohol related disorder.~* History of sleep apnea.~* Positive urine drug screen (UDS) for other that marijuana.~* Positive for Hepatitis B or C and HIV on Screening.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- Treatment A (Type: PLACEBO_COMPARATOR): None
- Treatment B (Type: EXPERIMENTAL): None
- Treatment C (Type: EXPERIMENTAL): None
- Treatment D (Type: ACTIVE_COMPARATOR): None
- Treatment E (Type: EXPERIMENTAL): None
- Treatment F (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).